The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; MSD Oncology
Research Funding - MSD Oncology (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche/Genentech; Roche/Genentech
Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma.
 
Emilie Le Rhun
Consulting or Advisory Role - Daiichi Sankyo; Tocagen
Research Funding - Amgen (Inst); Mundipharma (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Fabian Wolpert
No Relationships to Disclose
 
Maud Fialek
No Relationships to Disclose
 
Patrick Devos
No Relationships to Disclose
 
Nicolaus Andratschke
No Relationships to Disclose
 
Nicolas Reyns
No Relationships to Disclose
 
Reinhard Dummer
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Roche; Sanofi; Sun Pharma; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Laurent Mortier
No Relationships to Disclose
 
Michael Weller
Honoraria - Abbvie; Merck Serono; MSD
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Karyopharm Therapeutics; Merck Serono; Orbus Therapeutics; Tocagen
Research Funding - Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); OGD2 Pharma (Inst); Piqur (Inst); Roche (Inst); Tragara (Inst)